
Corporate venture arm of Northwestern Mutual investing in financial, health and analytics technology, plus a Wisconsin startup fund

Investor in early to growth-stage digital health startups

Dedicated to digital health, DigiTx Partners invests in and supports early to growth stage companies in the field. The firm says it was launched in 2016 and remains one of the few venture funds devoted exclusively to digital health. It backs founders and leaders who use technology and meaningful data to drive change across healthcare and the life sciences, and it describes itself as an active investor that builds strong relationships with its portfolio companies.
The firm argues that health is moving away from one-size-fits-all treatment toward a more personal definition. It believes that combining genomics and other omics data, clinical records, behavioral data and social interactions allows treatment and prevention to be tailored to each patient. It wants to back solutions that can generate meaningful data, analyze it intelligently and show competitive insight into patient and population outcomes.
The firm says evidence-based, clinically validated digital interventions can improve outcomes by managing or preventing disease, optimizing medication or treating a condition directly. It expects a future in which software is routinely prescribed for acute and chronic conditions. It is also interested in the microbiome: the trillions of microorganisms in the human body, whose genetic diversity could support new diagnostics and therapies. Its wider interest extends to frontier areas such as virtual and augmented reality, neurotechnology and blockchain.
The firm says it is at an early stage of applying technology to cognitive and behavioral conditions, from attention deficit to depression, and it wants to support emerging players that address those conditions and grow the behavioral health market. Its site also highlights portfolio themes such as earlier detection of heart and lung disease, software and data analytics for precision neurology, and AI-enabled insight that improves patient outcomes. Recent news covers a startup using AI to help patients access specialty drugs.
The company says its team focuses on digital health alone, and that a managing director leads the firm's investment work. It describes its investors as active participants who share the work of building portfolio companies.
DigiTx Partners invests in and supports startups in digital health. It looks for founders and leaders using technology and meaningful data to change healthcare and life sciences.
Companies in areas it names as priorities: behavioural health, personalised medicine using genomic and clinical data, evidence-based digital therapeutics, and microbiome-based diagnostics and treatments. It is also open to emerging technologies such as VR and AR, neurotech and blockchain.
Summary written by TrustList from the business's own published information, Nov 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about DigiTx Partners.
Similar listings buyers compare against this one.

Corporate venture arm of Northwestern Mutual investing in financial, health and analytics technology, plus a Wisconsin startup fund

Philadelphia venture capital firm investing in early-stage and emerging-growth technology businesses

A crypto collective giving blockchain startups marketing, strategy and early backing

Online platform in India connecting early-stage startups with investors and managing their equity

Investment firm partnering with venture and growth funds to gain exposure to Chinese companies

Family-rooted investment firm backing businesses through growth and change with long-term capital

Deep technology venture capital firm investing in semiconductors, AI, infrastructure software and bio-convergence

Corporate venture fund of UCB investing in early-stage healthcare and biotech start-ups in the US and Europe
Everything here links back to the same verified catalogue. Pick your next stop.